Egypt Education Platform's EEP Run raises funds for Gaza    IMF approves $1.5m loan to Bangladesh    China in advanced talks to join Digital Economy Partnership Agreement    Egypt's annual inflation declines to 31.8% in April – CAPMAS    Chimps learn and improve tool-using skills even as adults    13 Million Egyptians receive screenings for chronic, kidney diseases    Al-Mashat invites Dutch firms to Egypt-EU investment conference in June    Asian shares steady on solid China trade data    Trade Minister, Building Materials Chamber forge development path for Shaq El-Thu'ban region    Cairo mediation inches closer to Gaza ceasefire amidst tensions in Rafah    Taiwan's exports rise 4.3% in April Y-Y    Microsoft closes down Nigeria's Africa Development Centre    Global mobile banking malware surges 32% in 2023: Kaspersky    Mystery Group Claims Murder of Businessman With Alleged Israeli Ties    Egypt, World Bank evaluate 'Managing Air Pollution, Climate Change in Greater Cairo' project    US Embassy in Cairo announces Egyptian-American musical fusion tour    Japanese Ambassador presents Certificate of Appreciation to renowned Opera singer Reda El-Wakil    Sweilam highlights Egypt's water needs, cooperation efforts during Baghdad Conference    AstraZeneca injects $50m in Egypt over four years    Egypt, AstraZeneca sign liver cancer MoU    Swiss freeze on Russian assets dwindles to $6.36b in '23    Amir Karara reflects on 'Beit Al-Rifai' success, aspires for future collaborations    Climate change risks 70% of global workforce – ILO    Prime Minister Madbouly reviews cooperation with South Sudan    Egypt retains top spot in CFA's MENA Research Challenge    Egyptian public, private sectors off on Apr 25 marking Sinai Liberation    Debt swaps could unlock $100b for climate action    President Al-Sisi embarks on new term with pledge for prosperity, democratic evolution    Amal Al Ghad Magazine congratulates President Sisi on new office term    Egyptian, Japanese Judo communities celebrate new coach at Tokyo's Embassy in Cairo    Uppingham Cairo and Rafa Nadal Academy Unite to Elevate Sports Education in Egypt with the Introduction of the "Rafa Nadal Tennis Program"    Financial literacy becomes extremely important – EGX official    Euro area annual inflation up to 2.9% – Eurostat    BYD، Brazil's Sigma Lithium JV likely    UNESCO celebrates World Arabic Language Day    Motaz Azaiza mural in Manchester tribute to Palestinian journalists    Russia says it's in sync with US, China, Pakistan on Taliban    It's a bit frustrating to draw at home: Real Madrid keeper after Villarreal game    Shoukry reviews with Guterres Egypt's efforts to achieve SDGs, promote human rights    Sudan says countries must cooperate on vaccines    Johnson & Johnson: Second shot boosts antibodies and protection against COVID-19    Egypt to tax bloggers, YouTubers    Egypt's FM asserts importance of stability in Libya, holding elections as scheduled    We mustn't lose touch: Muller after Bayern win in Bundesliga    Egypt records 36 new deaths from Covid-19, highest since mid June    Egypt sells $3 bln US-dollar dominated eurobonds    Gamal Hanafy's ceramic exhibition at Gezira Arts Centre is a must go    Italian Institute Director Davide Scalmani presents activities of the Cairo Institute for ITALIANA.IT platform    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



Warning against use of 14 blood pressure drugs in Egypt
Published in Ahram Online on 26 - 07 - 2018

Egypt's consumer protection agency issued a warning in cooperation with the Ministry of Health, cautioning citizens against using 14 types of blood pressure drug, since they contain an ingredient that may cause cancer, according to a statement by the consumer protection agency.
Head of the consumer agency Rady Abdel Moaty said that the Egyptian Pharmacists Syndicate had previously issued a warning to all doctors against using any of the mentioned drugs.
The 14 drugs have been assessed as containing an excessive dosage of the active ingredient in "valsartan," which is known to be a generic agent used to treat high blood pressure and heart failure.
The substance used in valsartan is normally only used in limited proportions.
Valesartan, manufactured by a Chinese company, has been produced with higher than normal proportions of the substance according to the European Medicines Agency (EMA), causing an impurity in 14 blood pressure drugs which pose a potential cancer risk.
EMA is an agency of the European Union responsible for the scientific evaluation, supervision and safety monitoring of medicines.
According to an earlier notice issued by the Egyptian Health Ministry the 14 drugs are named as follows:
1. Valsarcard 80mg tab

5. Pressthioval tab

8. Disartan 80mg cap

12. Amilo Plus tab

2. Valsarcard Comb 80/12.5mg tab

6. Zarlodip tab

9. Disartan Co 80mg cap

13. Blokatens 5/160mg tab

3. Valsarcard Comb 160/12.5mg tab

7. Alkapress Plus 5/160mg F.C. tab

10. Disartan 160mg cap

14. Blokatens 10/160mg tab

4. Elimolivan 5/160mg tab

11. Disartan Co 160mg cap



Abdel Moaty says that the consumer protection authority has contacted all representatives of the pharmaceutical companies producing these drugs, instructing them to withdraw all of them from pharmacies immediately.
He stressed that the system would take the necessary action in cooperation with other regulatory bodies to ensure that companies would comply with the withdrawal of the drugs.
He pointed out that consumer protection campaigns will increase during the coming period to control the markets and ensure the safety of citizens.


Clic here to read the story from its source.